Learn about WAKIX resources and support
Here, you can find resources and downloads to help you learn more about WAKIX and find support once you've been prescribed WAKIX.
Patient support program
Once your healthcare provider prescribes WAKIX® (pitolisant), you have the option to sign up for WAKIX for You, a patient support program that provides individualized support based on your specific needs and eligibility.Learn More
Stay informed about WAKIX
Whether you're interested in learning more about WAKIX or you or a loved one have already started taking WAKIX, sign up to receive resources that can provide support throughout your journey and help prepare you for discussions with your healthcare provider.Sign up
WAKIX educational brochure
Whether you're newly diagnosed or have been diagnosed for years and are ready for a change, learn how WAKIX might help manage your symptoms of excessive daytime sleepiness (EDS) or cataplexy.Download now
Get started with WAKIX
When starting a medication, it is important to talk to your healthcare provider so he or she can help you understand what to expect. This guide includes a few things to discuss with your healthcare provider when starting WAKIX.Download now
Indications and usage & Important Safety Information
Important Safety Information
Do not take WAKIX if you are allergic to pitolisant or any ingredient in WAKIX, or if you have severe liver disease.
Tell your healthcare provider about all your medical conditions, including if you have heart rhythm irregularities, were born with a heart condition, or the levels of electrolytes in your blood are too high or too low. WAKIX has an effect on the electrical activity of the heart known as QT/QTc prolongation. Medicines with this effect can lead to disturbances in heart rhythm, which are more likely in patients with risk factors such as certain heart conditions, or when taken in combination with other medicines that affect QT. Tell your healthcare provider about all the other medicines you take.
The risk of QT prolongation may be greater in patients with liver or kidney disease. WAKIX is not recommended in patients with end-stage kidney disease.
The most common side effects seen with WAKIX were insomnia, nausea, and anxiety. Other side effects included headache, upper respiratory infection, musculoskeletal pain, heart rate increased, and decreased appetite. These are not all the possible side effects of WAKIX. Tell your healthcare provider about any side effect that bothers you or that does not go away.
Tell your healthcare provider about all the medicines you take or plan to take, including prescription and over-the-counter medicines. Some medicines can increase the amount of WAKIX that gets into your blood and some medicines can decrease the amount of WAKIX that gets into your blood. The dosage of WAKIX may need to be adjusted if you are taking these medicines.
WAKIX can also decrease the effectiveness of some medicines, including hormonal birth control methods. You should use an alternative non-hormonal birth control method during treatment with WAKIX and for at least 21 days after discontinuation of treatment.
Tell your healthcare provider if you are pregnant or planning to become pregnant. There is a pregnancy exposure registry that monitors pregnancy outcomes in women who are exposed to WAKIX during pregnancy. You are encouraged to enroll in the WAKIX pregnancy registry if you become pregnant while taking WAKIX. To enroll or obtain information from the registry, call 1-800-833-7460.
The safety and effectiveness of WAKIX have not been established in patients less than 18 years of age.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You can also report negative side effects to Harmony Biosciences at 1-800-833-7460.
Please see Full Prescribing Information.
Indications and Usage
WAKIX is a prescription medicine used to treat excessive daytime sleepiness (EDS) or sudden onset of weak or paralyzed muscles (cataplexy) in adults with narcolepsy.
You are now leaving the patient site.
This information is intended only for US healthcare professionals. If you are a healthcare professional, click “I agree” to continue.